# Drugs for the Treatment of Partial Onset Seizures: Extrapolation of Efficacy from Adults to Pediatric Patients  1 Month of Age and Older - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/drugs-for-the-treatment-of-partial-onset-seizures-extrapolation-of-efficacy-from-adults-to-pediatric-patients-1-month-of-age-and-older/522e1ab7-d361-4026-b798-06e21bfaaa5e

> FDA guidance document: Drugs for the Treatment of Partial Onset Seizures: Extrapolation of Efficacy from Adults to Pediatric Patients  1 Month of Age and Older. Issue date: July 15, 2024. Get complete insights and analysis.

---

## Details

- Title: Drugs for the Treatment of Partial Onset Seizures: Extrapolation of Efficacy from Adults to Pediatric Patients  1 Month of Age and Older
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-07-15
- Last Changed: 2024-07-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-0178 ">FDA-2018-D-0178 </a>

## Related Documents

- [Controlled Correspondence Related to Generic Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/controlled-correspondence-related-to-generic-drug-development/55babf6e-6cea-4e6c-80f6-3892feff9aab)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)
- [Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-the-development-of-oligonucleotide-therapeutics-guidance-for-industry/716f5680-73b2-4cf4-a88d-c5ade3c8aecd)